person

Katharina C. V. H.

Country
Germany
Department
III. Medizinische Klinik, Hämatoonkologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 22 partner sites.

Specializations

Hematologic Malignancies

Investigator focuses on acute leukemias, various lymphomas, and multiple myeloma within the hematology‑oncology clinic.

  • Acute myeloid leukemia
  • Acute lymphoblastic leukemia
  • Diffuse large B‑cell lymphoma
  • Chronic lymphocytic leukemia
  • Relapsed/refractory multiple myeloma

Research is conducted at Universitätsklinikum Heidelberg AöR and Heidelberg University.

Breast Oncology

Investigator engages in studies of hormone receptor‑positive and HER2‑negative breast cancer, spanning metastatic and early‑stage disease.

  • Advanced HR+/HER2‑negative breast cancer
  • Triple‑negative breast cancer
  • HER2‑positive breast cancer
  • Early‑stage HER2‑positive breast cancer
  • BRCA‑mutated breast cancer

Clinical insights are integrated with the department’s oncology program.

Amyloidosis & Cardiovascular Disorders

Research includes AL amyloidosis, ATTR amyloidosis, and associated heart failure syndromes.

  • Systemic AL amyloidosis
  • Transthyretin‑mediated cardiac amyloidosis (ATTR‑CM)
  • Heart failure with reduced ejection fraction
  • Atherosclerotic cardiovascular disease
  • Elevated lipoprotein(a) risk

These studies leverage the cardiovascular expertise of the clinical unit.

Autoimmune & Inflammatory Diseases

Investigator addresses systemic autoimmune conditions such as systemic lupus erythematosus and lupus nephritis.

  • Systemic lupus erythematosus
  • Lupus nephritis (active proliferative)
  • Chronic idiopathic thrombocytopenic purpura
  • Atopic dermatitis
  • Moderate‑to‑severe plaque psoriasis

Therapeutic strategies target immune modulation across these disorders.

Renal & Metabolic Disorders

Focus extends to renal pathologies including chronic kidney disease, autosomal dominant polycystic kidney disease, and metabolic lipid disorders.

  • Chronic kidney disease (CKD)
  • Autosomal dominant polycystic kidney disease (ADPKD)
  • Hyperlipidemia
  • Hypercholesterolemia
  • Hypertension

These investigations contribute to the multidisciplinary care model of the clinic.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.